A Novel Bispecific Antibody Targeting EGFR and VEGFR2 Is Effective against Triple Negative Breast Cancer via Multiple Mechanisms of Action. - Mohan N; Luo X; Shen Y; Olson Z; Agrawal A; Endo Y; Rotstein DS; Pelosof LC; Wu WJ (Cancers, 2021)